Contrasting requirements during disease evolution identify EZH2 as a therapeutic target in AML

Summary

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Faisal Basheer, George Giotopoulos, Eshwar Meduri, Haiyang Yun, Milena Mazan, Daniel Sasca, Paolo Gallipoli, Ludovica Marando, Malgorzata Gozdecka, Ryan Asby, Olivia Sheppard, Monika Dudek, Lars Bullinger, Hartmut Döhner, Richard Dillon, Sylvie Freeman, Oliver Ottmann, Alan Burnett, Nigel Russell, Elli Papaemmanuil, Robert Hills, Peter Campbell, George S. Vassiliou, Brian J.P. Huntly

Journal title: Journal of Experimental Medicine

Journal number: 216/4

Journal publisher: Rockefeller University Press

Published year: 2019

Published pages: 966-981

DOI identifier: 10.1084/jem.20181276

ISSN: 0022-1007